ARMATA PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 24.82 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-10
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 24.82M shares, a 34.93% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 24.76M shares, a 34.97% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 20.46M shares, a 95.74% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 18.39M shares.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 9.84M shares, a 81.82% increase from fiscal 2015.
- ARMATA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 5.41M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | 24.82M shares 10-Q · filed 2021-11-10 | 24.79M shares derived: average of 2 quarters · filed 2021-11-10 | 23.36M shares 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | 24.76M shares 10-Q · filed 2021-08-12 | 22.62M shares 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 20.46M shares 10-Q · filed 2021-05-13 | ||||
| 2020-09-30 | 18.39M shares 10-Q · filed 2021-11-10 | 18.37M shares derived: average of 2 quarters · filed 2021-11-10 | 15.74M shares 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 18.35M shares 10-Q · filed 2021-08-12 | 14.40M shares 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | 10.45M shares 10-Q · filed 2021-05-13 | ||||
| 2019-06-30 | 7.51M shares 10-Q · filed 2020-08-13 | 6.09M shares 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | 4.65M shares 10-Q · filed 2020-05-14 | 32.39M shares 10-Q · filed 2019-05-06 | |||
| 2018-03-31 | 13.30M shares 10-Q · filed 2019-05-06 | ||||
| 2017-03-31 | 1.68M shares 10-Q · filed 2018-05-15 | ||||
| 2016-12-31 | 9.84M shares 10-K · filed 2017-03-27 | ||||
| 2016-03-31 | 588.35K shares 10-Q · filed 2017-05-15 | ||||
| 2015-12-31 | 5.41M shares 10-K · filed 2017-03-27 | ||||
| 2015-03-31 | 212.29M shares 10-Q · filed 2015-05-15 | ||||
| 2014-03-31 | 182.54M shares 10-Q · filed 2015-05-15 | ||||
| 2013-12-31 | 101.20M shares 10-Q/A · filed 2015-04-15 | ||||
| 2013-03-31 | 66.91M shares 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |